Clinical Research Directory

Inclusion Criteria: * Informed Consent signed by the subject * Age ≥21 years old at the time of study entry * Currently receiving standard-of-care systemic anti-cancer therapy (chemotherapy, immunotherapy, endocrine and/or targeted therapy) for solid organ malignancy * Scheduled to be undergoing routine venous laboratory blood tests as part of the standard of care OR willing to undergo a research-specific venous draw to obtain a complete/full blood count (CBC/FBC) Exclusion Criteria: * History or current diagnosis of hematological malignancy (including bone and lymph) * Patients who self-report disabilities or issues with their eyesight, hearing or dexterity that they believe will preclude the use of Liberty, and who do not have a carer who can assist them. * Patients who have had prior experience using Liberty * Inadequate use and understanding of the English language, requiring a translator Carer eligibility: * Age ≥ 21 years old at the time of study entry * Can provide written informed consent * Do NOT self-report disabilities or issues with their eyesight, hearing or dexterity that they believe will preclude the use of Liberty * Have NOT had prior experience using Liberty * Adequate use and understanding of the English language; NOT requiring a translator